In order to patent a new chemical compound, which is to be used for medical purposes, it is necessary to present already in the patent application the results of a research confirming its therapeutic effects.

In the latest issue of the magazine “The World of Pharmaceutical Industry” (“Świat Przemysłu Farmaceutycznego”) Barbara Milczarek, a patent attorney at Patpol, discussed the obligation of a sufficient disclosure of invention in the context of the application procedures.

We invite you to read the full article in polish.

Essential tips on brand protection in Poland

Patpol has picked up the Prosecution Firm of the Year award for Poland at the Czytaj dalej

“R in a circle” or what the symbols next to the trademarks mean?

Today we are answering a number of questions that are continuously puzzling you: When the Czytaj dalej

New patent attorneys at Patpol

Due to constant development of the company, and in response to the growing demand from Czytaj dalej